Article info

Download PDFPDF

Original article
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis

Authors

  1. Correspondence to Pr Philippe Dieudé; philippe.dieude{at}aphp.fr
View Full Text

Citation

Juge P, Gazal S, Constantin A, et al
Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis

Publication history

  • Received February 1, 2017
  • Revision received September 13, 2017
  • Accepted September 14, 2017
  • First published September 28, 2017.
Online issue publication 
September 28, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.